522 related articles for article (PubMed ID: 33515428)
1. Intranasal Insulin for Alzheimer's Disease.
Hallschmid M
CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
[TBL] [Abstract][Full Text] [Related]
2. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease.
Kellar D; Lockhart SN; Aisen P; Raman R; Rissman RA; Brewer J; Craft S
J Prev Alzheimers Dis; 2021; 8(3):240-248. PubMed ID: 34101779
[TBL] [Abstract][Full Text] [Related]
4. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
[TBL] [Abstract][Full Text] [Related]
5. Intranasal insulin.
Hallschmid M
J Neuroendocrinol; 2021 Apr; 33(4):e12934. PubMed ID: 33506526
[TBL] [Abstract][Full Text] [Related]
6. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S
J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773
[TBL] [Abstract][Full Text] [Related]
7. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
[TBL] [Abstract][Full Text] [Related]
8. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
Ott V; Benedict C; Schultes B; Born J; Hallschmid M
Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
[TBL] [Abstract][Full Text] [Related]
10. A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease.
Rosenbloom M; Barclay TR; Kashyap B; Hage L; O'Keefe LR; Svitak A; Pyle M; Frey W; Hanson LR
Drugs Aging; 2021 May; 38(5):407-415. PubMed ID: 33719017
[TBL] [Abstract][Full Text] [Related]
11. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
Avgerinos KI; Kalaitzidis G; Malli A; Kalaitzoglou D; Myserlis PG; Lioutas VA
J Neurol; 2018 Jul; 265(7):1497-1510. PubMed ID: 29392460
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and clinical implications of intranasal insulin administration to the central nervous system.
Santiago JCP; Hallschmid M
Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
Mustapic M; Tran J; Craft S; Kapogiannis D
J Alzheimers Dis; 2019; 69(2):489-498. PubMed ID: 30958348
[TBL] [Abstract][Full Text] [Related]
14. Intranasal insulin in Alzheimer's disease: Food for thought.
Chapman CD; Schiöth HB; Grillo CA; Benedict C
Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
[TBL] [Abstract][Full Text] [Related]
15. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
[TBL] [Abstract][Full Text] [Related]
16. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
[TBL] [Abstract][Full Text] [Related]
17. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C
CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722
[TBL] [Abstract][Full Text] [Related]
18. Intranasal insulin to improve memory function in humans.
Benedict C; Hallschmid M; Schultes B; Born J; Kern W
Neuroendocrinology; 2007; 86(2):136-42. PubMed ID: 17643054
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
[TBL] [Abstract][Full Text] [Related]
20. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
Hölscher C
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S33-7. PubMed ID: 24529523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
